Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.
Published January 23, 2013 · Recall initiated: December 10, 2012
Summary
FDA records drug Class III recall D-127-2013, published January 23, 2013 and initiated December 10, 2012. Recalling firm: Upsher Smith Laboratories, Inc.; Status: Terminated; Reported quantity: 11,316 bottles; Lot: Lot #: 310162, Exp 09/14. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Upsher Smith Laboratories, Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 310162, Exp 09/14
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs,April 30, 2014
- FDAPropranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured forFebruary 20, 2013
- FDAPerindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane LaboratoriesJanuary 23, 2013
- FDACABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA,January 23, 2013
- FDAPrednisone tablets, USP, 10mg, Rx Only, Units of Use, NDC: a) 45802-303-67, 48-count Cartons, b) 45802-303-21,January 23, 2013
- FDAI-C Drops, Eye Cleansing Agent, 15 ml ASN/Maxam P.O. Box 1277 Hood River, OR 97031January 23, 2013
Questions about this recall
Was Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11. recalled?
Yes. FDA published recall D-127-2013 on January 23, 2013. Reported hazard: Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone